Clinical Trial Update: Retrospective Survey of Re-treatment With Bortezomib

View source ↗

Summary

A retrospective study evaluating outcomes of patients with multiple myeloma treated again with bortezomib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Hematological Cancer, Multiple Myeloma | Status: COMPLETED